Nemaura Medical Inc.
(NMRD)
undefined
undefined%
At close: undefined
0.12
59900.00%
After-hours Jan 04, 2024, 05:57 PM EST
Company Description
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices.
It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients.
The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs.
Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.
Nemaura Medical Inc.
| Country | United States |
| IPO Date | Feb 5, 2018 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 36 |
| CEO | Dr. Dewan Fazlul Hoque Chowdhury Ph.D. |
Contact Details
Address: 57 West 57th Street New York, New York United States | |
| Website | https://nemauramedical.com |
Stock Details
| Ticker Symbol | NMRD |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001602078 |
| CUSIP Number | 640442208 |
| ISIN Number | US6404422080 |
| Employer ID | 46-5027260 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dr. Dewan Fazlul Hoque Chowdhury Ph.D. | Chairman, Interim Chief Financial Officer, Chief Executive Officer, President and Principal Financial & Accounting Officer |
| Jay L. Warner | Head of U.S. Commercial Operations |
| Samantha Sanders | Global Head of Digital Programs |
| Thomas Bendix Mortensen | Head of E.U. Commercial Operations & Marketing |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 26, 2024 | 8-K | Current Report |
| Jul 01, 2024 | DEF 14C | Filing |
| Jul 01, 2024 | NT 10-K | Filing |
| May 17, 2024 | 8-K | Current Report |
| Apr 22, 2024 | 8-K | Current Report |
| Apr 19, 2024 | PRE 14C | Filing |
| Apr 10, 2024 | 8-K | Current Report |
| Mar 21, 2024 | 25-NSE | Filing |
| Feb 26, 2024 | 8-K | Current Report |
| Feb 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |